Home About Case Studies Hire Me Contact
Currently available for select engagements

Hire Digital Marketing Expert for Biotech Startups
Senior, direct, no layers

Hire a Digital Marketing Expert for Biotech Startups: marketing that brings enquiries, measured against enquiries, built around assay development and validation.

15+
Years Experience
100+
Projects Delivered
6
Countries Served
$25M+
Revenue Enabled
Biotech Startups — Digital Marketing Expert

A senior digital marketing expert for biotech startups

The scarcest resource at a biotech startup is focused scientific time. Every hour a scientist spends reformatting data, chasing a CRO, or rebuilding an investor update is an hour not spent on the science the company exists to do.

A digital marketing expert brings the right visitors to the organization and turns them into enquiries: search, paid, social, and email working as one plan instead of separate experiments. For biotech startups, that means campaigns built around assay development and validation and the questions research partners, investors, and CRO teams ask before they commit.

Picture a CRO dataset arriving in a format nobody can use, days before an investor update is due. In that situation, a campaign aimed at the exact question behind the search, landing on a page that answers it and captures the enquiry, would turn passing attention into a real conversation. Book a free discovery call and we will test the fit on one real workflow before any wider scope is agreed.

What you get

What this engagement covers for Biotech Startups

  • A channel plan for assay development and validation: which channels reach research partners, investors, and CRO teams here, what each must produce, and what to stop spending on.
  • Search and paid campaigns built around the actual services, with landing pages that match the ad instead of dumping visitors on a homepage.
  • A lead capture and follow-up routine connected to an electronic lab notebook such as Benchling where possible, so enquiries are answered fast and none are lost.
  • An email and retargeting routine for visitors who are not ready yet, kept useful and restrained rather than noisy.
  • Creative and copy the team can reuse: messages that explain the offer plainly, without hype the organization cannot stand behind.
  • Reporting that ties spend to enquiries and bookings, so budget moves toward what works and away from what does not.
The systems Biotech Startups actually run

Built on your stack, not on top of it

The stack here is an electronic lab notebook such as Benchling, a LIMS, bioinformatics pipelines, and CRO data portals. The gap is usually connection, not tools: work lands in one system, records live in another, and nobody has one view of where a case stands. This engagement connects that stack and standardises the routines around it.

Campaigns and reporting connect to the organization's site and, where possible, to an electronic lab notebook such as Benchling so enquiries are tracked from click to conversation. No channel is reported in isolation from its results.

This page describes services, not scientific or regulatory advice. Research and regulatory decisions stay with the startup's qualified scientific staff. FDA IND and BLA pathways shapes what can be automated or changed, and the work is scoped to fit it rather than work around it.

How it works

From kickoff to delivery for Biotech Startups

  1. Audit what marketing does today

    Current spend, channels, and enquiry flow are audited, starting with where enquiries actually come from.

  2. Build the plan around enquiries

    Channels and landing pages are planned around assay development and validation and the enquiries it should produce.

  3. Launch in stages

    Campaigns launch in stages so each channel is judged on its own results before budget grows.

  4. Move budget on evidence

    Spend follows enquiries: what produces conversations grows, what produces only clicks shrinks.

Why Omer

Why hire Omer

  • Every channel judged on enquiries, not impressions
  • Landing pages that match the ad, not the homepage
  • Follow-up wired so no enquiry is lost
  • Creative the team can reuse and stand behind
  • Budget moved on evidence, not habit
Outcomes

What changes in practice

The realistic outcome is data the team can actually use: experiments findable, CRO results comparable, and updates assembled from real results instead of rebuilt each time.

Two problems deserve naming: experimental data scattered across notebooks and drives and CRO results arriving late or in unusable formats. Both persist when the underlying routine stays manual and nobody owns the follow-up, so each deliverable in this engagement is paired with a named owner and a visible queue, and problems surface while they are still small.

What changes is the pipeline: steadier enquiries from channels that prove themselves, and a marketing spend the leadership can defend.

Browse all hire engagements or discuss your biotech startup workflow directly.

FAQ

Questions, answered

Which channel should we start with?
The one where research partners, investors, and CRO teams already look for assay development and validation — usually search first, with paid and social added where they demonstrably produce enquiries.
How is marketing success measured?
By enquiries and bookings, not clicks or impressions. Reporting ties spend to conversations so budget decisions are honest.
Will marketing replace referrals?
No. It adds a second source of enquiries alongside referrals, so growth does not depend on a single channel.
How do you protect research data and intellectual property?
Research data stays inside the startup's own systems and approved tools, with access following existing permissions. Nothing is sent to a public tool or used to train a shared model, and digital marketing expert work work is scoped so unpublished results and IP stay under the company's control.
What would the first project be for biotech startups?
A sensible first project is one workflow — usually experiment data organization, or CRO reporting — with a clear measure such as less time spent assembling the next investor update. Starting narrow matters: one workflow done properly proves the fit before any wider scope is agreed, and the team gets documentation it can run without the builder.
Currently available for select engagements

Ready to get started?

The best way to explore working together is a quick conversation. Reach out through your preferred channel and let us discuss your project.